[go: up one dir, main page]

TN2013000134A1 - Combination therapy for treating hcv infection - Google Patents

Combination therapy for treating hcv infection

Info

Publication number
TN2013000134A1
TN2013000134A1 TNP2013000134A TN2013000134A TN2013000134A1 TN 2013000134 A1 TN2013000134 A1 TN 2013000134A1 TN P2013000134 A TNP2013000134 A TN P2013000134A TN 2013000134 A TN2013000134 A TN 2013000134A TN 2013000134 A1 TN2013000134 A1 TN 2013000134A1
Authority
TN
Tunisia
Prior art keywords
hcv infection
treating hcv
combination therapy
compound
pharmaceutically acceptable
Prior art date
Application number
TNP2013000134A
Other languages
French (fr)
Inventor
Wulf Boecher
Carla Haefner
George Kukolj
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/066567 external-priority patent/WO2012041771A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2013000134A1 publication Critical patent/TN2013000134A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) Compound (2), or a pharmaceutically acceptable salt thereof, as herein described, and optionally (c) ribavirin, and methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
TNP2013000134A 2011-09-23 2013-03-27 Combination therapy for treating hcv infection TN2013000134A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/066567 WO2012041771A1 (en) 2010-09-30 2011-09-23 Combination therapy for treating hcv infection

Publications (1)

Publication Number Publication Date
TN2013000134A1 true TN2013000134A1 (en) 2014-06-25

Family

ID=54360802

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000134A TN2013000134A1 (en) 2011-09-23 2013-03-27 Combination therapy for treating hcv infection

Country Status (1)

Country Link
TN (1) TN2013000134A1 (en)

Similar Documents

Publication Publication Date Title
PH12013500559A1 (en) Combination therapy for treating hcv infection
PH12014500386A1 (en) Combination treatment for hepatitis c
PH12018502489A1 (en) Antiviral therapy
MX2013003634A (en) Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases.
MX2014003180A (en) Methods for treating hcv.
PH12015500274A1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
AU2011328009A8 (en) Compounds and methods for treating pain
PH12014500832A1 (en) Methods for treating hcv
EA033257B1 (en) Combination of two antivirals for treating hepatitis c
PH12016502355A1 (en) Pharmaceutical composition
MX2013008074A (en) Combination.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
PH12012500827A1 (en) Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin
PH12014500381A1 (en) Therapeutic methods
TW201129361A (en) Methods for treating pain
MX2013007055A (en) Sanglifehrin derivatives and methods for their production.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
PH12013500027A1 (en) Therapeutic agents 976
TN2013000134A1 (en) Combination therapy for treating hcv infection
UA98508C2 (en) Immunomodulatory dipeptide derivative for the treatment of lung cancer